glp 1 and antipsychotics GLP-1 Antipsychotic Weight Gain: A New Treatment Option Beyond GLP-1 Agonists: An Adaptive
Description
doi: 10.1113/expphysiol.2007.041848
Similarly, the REWIND trial showed a stronger impact of dulaglutide on nonfatal stroke (HR 0.76
Your provider can weigh genetic predispositions, your clinical history, available formulations, and financial sustainability to select the most appropriate GLP-1 option
Physician-supervised GLP-1 therapy
Preserve muscle through resistance training, high protein intake, and creatine supplementation
The therapeutic potential of GLP-1 has been realized using two pharmacologic approaches
